Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 35, Issue 5, Pages 363–367
http://dx.doi.org/10.1155/2013/274515
Clinical Study

Diagnostic Significance of Serum Eotaxin-1 Level in Gastric Cancer Patients

1Department of Gastroenterologic Surgery, Turkiye Yuksek Ihtisas Education and Research Hospital, 06100 Ankara, Turkey
2Department of General Surgery, Ankara Numune Education and Research Hospital, 5.cadde 10/3 Bahçelievler, 06100 Ankara, Turkey
3Department of Biochemistry, Istanbul University Cerrahpasa Medical Faculty, 34098 Istanbul, Turkey

Received 7 June 2013; Revised 5 August 2013; Accepted 23 August 2013

Academic Editor: Stamatios Theocharis

Copyright © 2013 Ümit Koç et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M. J. Thun, “Cancer statistics, 2009,” CA Cancer Journal for Clinicians, vol. 59, no. 4, pp. 225–249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. K. D. Crew and A. I. Neugut, “Epidemiology of gastric cancer,” World Journal of Gastroenterology, vol. 12, no. 3, pp. 354–362, 2006. View at Google Scholar · View at Scopus
  3. H. Brenner, D. Rothenbacher, and V. Arndt, “Epidemiology of stomach cancer,” Methods in Molecular Biology, vol. 472, pp. 467–477, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. P. Jiang, X. H. Wu, H. Y. Xing, and X. Y. Du, “Role of CXCL12 in metastasis of human ovarian cancer,” Chinese Medical Journal, vol. 120, no. 14, pp. 1251–1255, 2007. View at Google Scholar · View at Scopus
  5. H. Kishimoto, Z. Wang, P. Bhat-Nakshatri, D. Chang, R. Clarke, and H. Nakshatri, “The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1α/CXCL12,” Carcinogenesis, vol. 26, no. 10, pp. 1706–1715, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Meijer, I. S. Zeelenberg, B. Sipos, and E. Roos, “The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver,” Cancer Research, vol. 66, no. 19, pp. 9576–9582, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Metzner, C. Hofmann, C. Heinemann et al., “Overexpression of CXC-chemokines and CXC-chemokine receptor type II constitute an autocrine growth mechanism in the epidermoid carcinoma cells KB and A431,” Oncology Reports, vol. 6, no. 6, pp. 1405–1410, 1999. View at Google Scholar · View at Scopus
  8. A. Zlotnik, “Chemokines and cancer,” International Journal of Cancer, vol. 119, no. 9, pp. 2026–2029, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Salcedo, H. A. Young, M. L. Ponce et al., “Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells,” Journal of Immunology, vol. 166, no. 12, pp. 7571–7578, 2001. View at Google Scholar · View at Scopus
  10. L. A. Beck, B. Tancowny, M. E. Brummet et al., “Functional analysis of the chemokine receptor CCR3 on airway epithelial cells,” Journal of Immunology, vol. 177, no. 5, pp. 3344–3354, 2006. View at Google Scholar · View at Scopus
  11. D. Wågsäter, S. Löfgren, A. Hugander, O. Dienus, and J. Dimberg, “Analysis of single nucleotide polymorphism in the promoter and protein expression of the chemokine Eotaxin-1 in colorectal cancer patients,” World Journal of Surgical Oncology, vol. 5, p. 84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. S. B. Edge, D. R. Byrd, C. C. Compton, A. G. Fritz, F. L. Greene, and A. A. Trotti, Eds., AJCC Cancer Staging Manual, Springer, New York, NY, USA, 7th edition, 2010.
  13. P. Rotkrua, S. Shimada, K. Mogushi, Y. Akiyama, H. Tanaka, and Y. Yuasa, “Circulating microRNAs as biomarkers for early detection of diffuse-type gastric cancer using a mouse model,” British Journal of Cancer, vol. 108, pp. 932–940, 2013. View at Publisher · View at Google Scholar
  14. S. M. Rankin, D. M. Conroy, and T. J. Williams, “Eotaxin and eosinophil recruitment: implications for human disease,” Molecular Medicine Today, vol. 6, no. 1, pp. 20–27, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. M. E. Rothenberg, “Eosinophilic gastrointestinal disorders (EGID),” Journal of Allergy and Clinical Immunology, vol. 113, no. 1, pp. 11–29, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. S. C. M. Lorena, D. T. Oliveira, R. G. Dorta, G. Landman, and L. P. Kowalski, “Eotaxin expression in oral squamous cell carcinomas with and without tumour associated tissue eosinophilia,” Oral Diseases, vol. 9, no. 6, pp. 279–283, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Yasumoto, K. Koizumi, A. Kawashima et al., “Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer,” Cancer Research, vol. 66, no. 4, pp. 2181–2187, 2006. View at Google Scholar
  18. K. Jöhrer, C. Zelle-Rieser, A. Perathoner et al., “Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma,” Clinical Cancer Research, vol. 11, no. 7, pp. 2459–2465, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Agarwal, C. He, J. Siddiqui, J. T. Wei, and J. A. Macoska, “CCL11 (eotaxin-1): a new diagnostic serum marker for prostate cancer,” The Prostate, vol. 73, no. 6, pp. 573–581, 2013. View at Publisher · View at Google Scholar
  20. Z. Yurkovetsky, S. Ta'asan, S. Skates et al., “Development of multimarker panel for early detection of endometrial cancer. High diagnostic power of prolactin,” Gynecologic Oncology, vol. 107, no. 1, pp. 58–65, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. S. F. Zohny and S. T. Fayed, “Clinical utility of circulating matrix metalloproteinase-7 (MMP-7), CC chemokine ligand 18 (CCL18) and CC chemokine ligand 11 (CCL11) as markers for diagnosis of epithelial ovarian cancer,” Medical Oncology, vol. 27, no. 4, pp. 1246–1253, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Levina, B. M. Nolen, A. M. Marrangoni et al., “Role of eotaxin-1 signaling in ovarian cancer,” Clinical Cancer Research, vol. 15, no. 8, pp. 2647–2656, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. B. M. Nolen and A. E. Lokshin, “Targeting CCL11 in the treatment of ovarian cancer,” Expert Opinion on Therapeutic Targets, vol. 14, no. 2, pp. 157–167, 2010. View at Publisher · View at Google Scholar · View at Scopus